DNA moleucle

Epigenetics and pediatric brain tumors

DNA moleucle

Over the last two decades the critical role of epigenetics in cancer biology has evolved significantly. In parallel, our understanding of the biology of many pediatric brain tumors and the central role of alterations in their epigenetic regulation has become an important area of discovery.

In an editorial in a special issue of the Journal of Neuro-Oncology, Roger Packer, M.D., senior vice president of the Center for Neurosciences and Behavioral Medicine at Children’s National Hospital, looks at understanding the role of epigenetics and how they will further characterize pediatric brain tumors, open new therapeutic avenues for treatment and lead to true breakthroughs and cures for children.

You might also like
Randi StreisandRandi Streisand, Ph.D., appointed Chief of Psychology and Behavioral Health at Children’s National Health System
t cells fighting cancer cellPersonalized T cell immunotherapy for brain tumors closer to becoming reality
Jake and Dr. OluigboDoctors at Children’s National give Jake his life back
person with brain tumorUpdate on pediatric brain tumors
illustration of the brainLIFU successfully delivers targeted therapies past the blood-brain barrier
Javad NazarianMeeting of the minds: Children’s National hosts first DIPG Round Table Discussion